Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antibiotic resistance in the invasive bacteria Escherichia coli

V. Lovayová, K. Čurová, V. Hrabovský, M. Nagyová, L. Siegfried, A. Toporová, K. Rimárová, Š. Andraščíková

. 2022 ; 30 (Suppl.) : S75-S80. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033973

Digitální knihovna NLK
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 2004
ProQuest Central od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost) od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources od 1993

OBJECTIVES: The beta-lactamases with extended spectrum of activity (ESBL) are medically one of the most important group of enzymes. Another group of beta-lactamases representing of Enterobacteriaceae is group of the AmpC-type cephalosporinases. The presented study provides identification and determination of the spectrum of resistance against different and clinically used antimicrobial drugs in the clinical isolates of Escherichia coli. METHODS: These isolates had origin in different departments of the L. Pasteur University Hospital in Košice. The goal was the detection of beta-lactamase production with extended-spectrum effect and testing of AmpC-type cephalosporinases by several phenotypic tests in clinical isolates. MALDI-TOF MS analysis was performed on a Microflex MALDI Biotyper. Samples were positively tested for ESBL with the use of the disc diffusion method. PCR were performed with a series of primers designed for the detection of Ambler class A, B and C beta-lactamase genes. RESULTS: For all 485 isolates, we determined the production of ESBL, which we detected in 166 E. coli isolates, which represents a 34.2% prevalence of ESBL production. It is clear from the results that the prevalence of ESBL-producing E. coli out of the total number of E. coli investigated reached 34.2%. In the monitored period, we confirmed at least one resistance gene from 485 E. coli in 188 positive isolates. CONCLUSIONS: We describe a complex ESBL epidemiology. The study revealed a high rate of ESBL-producing E. coli isolates; blaTEM and blaSHV enzymes dominated in ESBL-positive E. coli isolates in the L. Pasteur University Hospital in Košice.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033973
003      
CZ-PrNML
005      
20230314090924.0
007      
ta
008      
230207s2022 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a7384 $2 doi
035    __
$a (PubMed)35841230
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Lovayová, Viera, $u Department of Medical and Clinical Microbiology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovak Republic $d 1972- $7 xx0283280
245    10
$a Antibiotic resistance in the invasive bacteria Escherichia coli / $c V. Lovayová, K. Čurová, V. Hrabovský, M. Nagyová, L. Siegfried, A. Toporová, K. Rimárová, Š. Andraščíková
520    9_
$a OBJECTIVES: The beta-lactamases with extended spectrum of activity (ESBL) are medically one of the most important group of enzymes. Another group of beta-lactamases representing of Enterobacteriaceae is group of the AmpC-type cephalosporinases. The presented study provides identification and determination of the spectrum of resistance against different and clinically used antimicrobial drugs in the clinical isolates of Escherichia coli. METHODS: These isolates had origin in different departments of the L. Pasteur University Hospital in Košice. The goal was the detection of beta-lactamase production with extended-spectrum effect and testing of AmpC-type cephalosporinases by several phenotypic tests in clinical isolates. MALDI-TOF MS analysis was performed on a Microflex MALDI Biotyper. Samples were positively tested for ESBL with the use of the disc diffusion method. PCR were performed with a series of primers designed for the detection of Ambler class A, B and C beta-lactamase genes. RESULTS: For all 485 isolates, we determined the production of ESBL, which we detected in 166 E. coli isolates, which represents a 34.2% prevalence of ESBL production. It is clear from the results that the prevalence of ESBL-producing E. coli out of the total number of E. coli investigated reached 34.2%. In the monitored period, we confirmed at least one resistance gene from 485 E. coli in 188 positive isolates. CONCLUSIONS: We describe a complex ESBL epidemiology. The study revealed a high rate of ESBL-producing E. coli isolates; blaTEM and blaSHV enzymes dominated in ESBL-positive E. coli isolates in the L. Pasteur University Hospital in Košice.
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a Bacteria $7 D001419
650    _2
$a antibiotická rezistence $7 D004352
650    12
$a Escherichia coli $x genetika $7 D004926
650    12
$a infekce vyvolané Escherichia coli $x epidemiologie $x mikrobiologie $7 D004927
650    _2
$a lidé $7 D006801
650    _2
$a beta-laktamasy $x genetika $x farmakologie $7 D001618
655    _2
$a časopisecké články $7 D016428
700    1_
$a Čurová, Katarína $u Department of Medical and Clinical Microbiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic $7 xx0151314
700    1_
$a Hrabovský, Vladimír $u Department of Medical and Clinical Microbiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic $7 xx0127547
700    1_
$a Nagyová, Mária $u Department of Medical and Clinical Microbiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic $7 xx0283335
700    1_
$a Siegfried, Leonard $u Department of Medical and Clinical Microbiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic $7 xx0136035
700    1_
$a Toporová, Annamária $u Department of Medical and Clinical Microbiology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic $7 xx0283333
700    1_
$a Rimárová, Kvetoslava, $u Department of Public Health and Hygiene, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic $d 1958- $7 xx0224806
700    1_
$a Andraščíková, Štefánia $u Department of Midwifery, Faculty of Health Care, University of Presov, Presov, Slovak Republic $7 xx0074507
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 30, Suppl. (2022), s. S75-S80
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35841230 $y Pubmed
910    __
$a ABA008 $b B 1829 $c 562 $y p $z 0
990    __
$a 20230207 $b ABA008
991    __
$a 20230314090921 $b ABA008
999    __
$a ok $b bmc $g 1896164 $s 1185362
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 30 $c Suppl. $d S75-S80 $e - $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
LZP    __
$b NLK198 $a Pubmed-20230207

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...